Entrada Therapeutics Inc (TRDA) — Cash Flow Quality Index
Entrada Therapeutics Inc (TRDA) has a Cash Flow Quality Index of -27.94x as of December 2024. Operating cash flow of $-31.61 Million is below net income of $1.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore TRDA total asset value for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Entrada Therapeutics Inc Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Entrada Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Entrada Therapeutics Inc (TRDA) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Entrada Therapeutics Inc (2024–2024)
Year-by-year earnings quality comparison for Entrada Therapeutics Inc. For live market cap and the full company financial profile, see how much is Entrada Therapeutics Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.63x | $-41.56 Million | $65.63 Million | — |